CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues

CPT-11 is a prodrug activated by carboxylesterases to the active metabolite SN-38 which is a potent inhibitor of topoisomerase I. CPT-11 is of clinical interest in the treatment of colorectal cancer. We evaluated the activities of CPT-11 converting carboxylesterase (CPT-CE) and topoisomerase I (topo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Guichard, S, Terret, C, Hennebelle, I, Lochon, I, Chevreau, P, Frétigny, E, Selves, J, Chatelut, E, Bugat, R, Canal, R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 1999
Konular:
Regular Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362335/
https://ncbi.nlm.nih.gov/pubmed/10408839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690364
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller